Cargando…

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients

Detalles Bibliográficos
Autores principales: Amir, E, Freedman, OC, Chia, S, Petrella, T, Dent, S, Tonkin, K, Ahmad, I, Rayson, D, Dranitsaris, G, Clemons, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284915/
http://dx.doi.org/10.1186/bcr2312
_version_ 1782351491783196672
author Amir, E
Freedman, OC
Chia, S
Petrella, T
Dent, S
Tonkin, K
Ahmad, I
Rayson, D
Dranitsaris, G
Clemons, M
author_facet Amir, E
Freedman, OC
Chia, S
Petrella, T
Dent, S
Tonkin, K
Ahmad, I
Rayson, D
Dranitsaris, G
Clemons, M
author_sort Amir, E
collection PubMed
description
format Online
Article
Text
id pubmed-4284915
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42849152015-01-15 Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients Amir, E Freedman, OC Chia, S Petrella, T Dent, S Tonkin, K Ahmad, I Rayson, D Dranitsaris, G Clemons, M Breast Cancer Res Poster Presentation BioMed Central 2009 2009-06-23 /pmc/articles/PMC4284915/ http://dx.doi.org/10.1186/bcr2312 Text en Copyright © 2009 BioMed Central Ltd.
spellingShingle Poster Presentation
Amir, E
Freedman, OC
Chia, S
Petrella, T
Dent, S
Tonkin, K
Ahmad, I
Rayson, D
Dranitsaris, G
Clemons, M
Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
title Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
title_full Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
title_fullStr Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
title_full_unstemmed Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
title_short Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
title_sort developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284915/
http://dx.doi.org/10.1186/bcr2312
work_keys_str_mv AT amire developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients
AT freedmanoc developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients
AT chias developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients
AT petrellat developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients
AT dents developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients
AT tonkink developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients
AT ahmadi developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients
AT raysond developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients
AT dranitsarisg developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients
AT clemonsm developingapredictionmodelforbenefitfromfulvestrantinheavilypretreatedmetastaticbreastcancerpatients